Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...

Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are ...

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Introduction: This study aimed to identify new clinical phenotypes of microscopic polyangiitis (MPA) using a principal components analysis (PCA)-based cluster analysis. Methods: A total of 189 ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Therapy for multiple sclerosis progression is a third major research theme. Inhibitors of Bruton's tyrosine kinase (BTK), an intracellular signalling enzyme expressed in B cells and most innate immune ...